ATC/DDD classification - WHO
ATC/DDD classification WHO Drug Information Vol. 29, No. 4, 2015 500 New DDDs: ATC level name/INN DDD unit Adm.R* ATC code alirocumab 5.4 mg P C10AX14 apremilast 60 mg O L04AA32 ataluren 2.8 g O M09AX03
Download ATC/DDD classification - WHO
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
SGLT-2 inhibiTorS: a perSpecTive on SafeTy and …
www.denovomedica.com1 earn 3 cpd poinTS onLine SGT T ORS January 2018 SGLT-2 inhibiTorS: a perSpecTive on SafeTy and ToLerabiLiTy KEY MESSAGES • Dapagliflozin is a new sodium glucose co-transporter-2 (SGLT-2) inhibitor for the treatment of
Na共役型グルコース 輸送体（SGLT ... - igaku.co.jp
www.igaku.co.jp6 月刊糖尿病 2015/7 vol.7 no.7 特 集sglt2阻害薬の新時代〜機序から臨床まで 1 na共役型グルコース輸送体（sglt）とは〜発見の歴史と生理機能 月刊糖尿病 2015/7 vol.7 no.7 7 1 グルコース naイオン シンポート （glut） ユニポート （sglt） naイオン グルコース c1 c2 c6 c5 c3 c4 図1 glutとsgltのグルコー
兩種口服糖尿病新藥SGLT-2抑制劑的選擇 及NNH為 …
www.tma.tw2017, vol.60, no.5 學 術 taiwan m edical journal 10 245 人狀況往往不盡相同。(2)上述討論中藥物的好處只挑 選了降血糖效果作為代表，而未考慮減重以及降血壓